Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_805
Snippet: Subconjunctival injection of VORI-GEL is safe. In normal horses, low AH and tear concentrations are likely due to intact ocular barriers and high drug lipophilicity. There is sustained release of therapeutic concentrations of voriconazole from the VORI-GEL to the anterior segment tissues for at least 2 days following injection. A diagnosis of inflammatory airway disease (IAD) is commonly based on abnormal bronchoalveolar lavage fluid (BALF) cytol.....
Document: Subconjunctival injection of VORI-GEL is safe. In normal horses, low AH and tear concentrations are likely due to intact ocular barriers and high drug lipophilicity. There is sustained release of therapeutic concentrations of voriconazole from the VORI-GEL to the anterior segment tissues for at least 2 days following injection. A diagnosis of inflammatory airway disease (IAD) is commonly based on abnormal bronchoalveolar lavage fluid (BALF) cytology or airway hyperreactivity (AHR) in horses with poor performance or chronic cough. Our study purpose was to determine whether two modalities of non-invasive lung function testing (FOM-forced oscillatory mechanics vs. RIP-Respiratory Inductive Plethysmography) establish the same clinical diagnosis of AHR, using histamine bronchoprovocation. AHR was defined by the histamine dose needed to double FOM baseline resistance, or to achieve a 35% increase in RIP delta flow.
Search related documents:
Co phrase search for related documents- clinical diagnosis and inflammatory airway disease: 1
- clinical diagnosis and lavage fluid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- clinical diagnosis and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- clinical diagnosis and poor performance: 1, 2, 3
- clinical diagnosis and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
- lung function and poor performance: 1, 2
- lung function and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- lung function and therapeutic concentration: 1, 2
- lung function testing and study purpose: 1
- poor performance and study purpose: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date